Insys Therapeutics, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Insys Therapeutics, Inc. had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value of $518.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue · last filed 2018-03-12
- 2017-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $518.00K.
- 2017-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $518.00K.
- 2017-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $518.00K.
- 2017-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value $518.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value |
|---|---|
| 2017-12-31 | $518.00K 10-K · filed 2018-03-12 |
| 2017-09-30 | $518.00K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $518.00K 10-Q · filed 2017-11-03 |
| 2017-03-31 | $518.00K 10-Q · filed 2017-08-07 |
| 2016-12-31 | $500.00K 10-K · filed 2018-03-12 |
| 2016-09-30 | $500.00K 10-Q · filed 2017-11-03 |
| 2016-06-30 | $500.00K 10-Q · filed 2017-11-03 |
| 2016-03-31 | $0.00 10-Q/A · filed 2017-04-07 |
| 2015-12-31 | $0.00 10-Q/A · filed 2017-04-07 |
| 2015-03-31 | $0.00 10-Q/A · filed 2017-04-07 |
| 2014-12-31 | $0.00 10-Q/A · filed 2017-04-07 |